These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11269478)

  • 1. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
    Kara M; Ohta Y; Tanaka Y; Oda M; Watanabe Y
    Ann Thorac Surg; 2001 Mar; 71(3):944-8. PubMed ID: 11269478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
    Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
    Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
    Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K; Raz A
    Int J Cancer; 2001 Nov; 95(6):384-7. PubMed ID: 11668522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
    Endo K; Shirai A; Furukawa M; Yoshizaki T
    Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
    Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
    Jiang WG; Raz A; Douglas-Jones A; Mansel RE
    J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers.
    Kawanishi K; Doki Y; Shiozaki H; Yano M; Inoue M; Fukuchi N; Utsunomiya T; Watanabe H; Monden M
    Am J Clin Pathol; 2000 Feb; 113(2):266-74. PubMed ID: 10664629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine motility factor receptor: a clinical review.
    Chiu CG; St-Pierre P; Nabi IR; Wiseman SM
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine motility factor-receptor gene expression in lung cancer.
    Takanami I; Takeuchi K
    Jpn J Thorac Cardiovasc Surg; 2003 Aug; 51(8):368-73. PubMed ID: 12962414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
    Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
    Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine motility factor receptor expression associates with tumor progression in thymoma.
    Ohta Y; Minato H; Tanaka Y; Go T; Oda M; Watanabe Y
    Int J Oncol; 2000 Aug; 17(2):259-64. PubMed ID: 10891533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein inwardly rectifying potassium channel 1 (GIRK 1) gene expression correlates with tumor progression in non-small cell lung cancer.
    Takanami I; Inoue Y; Gika M
    BMC Cancer; 2004 Nov; 4():79. PubMed ID: 15541182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
    Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
    Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
    Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gene product of the gp78/AMFR ubiquitin E3 ligase cDNA is selectively recognized by the 3F3A antibody within a subdomain of the endoplasmic reticulum.
    Registre M; Goetz JG; St Pierre P; Pang H; Lagacé M; Bouvier M; Le PU; Nabi IR
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1316-22. PubMed ID: 15303277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
    Korman HJ; Peabody JO; Cerny JC; Farah RN; Yao J; Raz A
    J Urol; 1996 Jan; 155(1):347-9. PubMed ID: 7490884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.